Drug Discovery

Deep within the microscopic confines of every human cell, a biological masterpiece unfolds not as a simple string of code but as a dynamic, three-dimensional sculpture that dictates life itself. A landmark study has now provided the most detailed and extensive atlas of this hidden architecture,

A promising class of anti-cancer drugs, designed with pinpoint precision to kill tumor cells, was abruptly sidelined by a mysterious and life-threatening side effect, leaving a potential breakthrough in oncology on the shelf. This clinical roadblock highlighted a fundamental challenge in modern

The perplexing reality that a medication meticulously designed to target cancer cells in the lungs can unexpectedly trigger adverse reactions in the heart has long been one of pharmacology's most frustrating and dangerous puzzles. For decades, the path a drug takes after being administered has been

In the complex world of hematologic malignancies, T-cell cancers represent a formidable challenge, often leaving patients with grim prognoses. We sat down with biopharma expert Ivan Kairatov to discuss a groundbreaking new approach that offers a glimmer of hope. In our conversation, he illuminates

Today, we're joined by Ivan Kairatov, a leading biopharma expert whose recent work has uncovered a startling new mechanism used by SARS-CoV-2. His team's research reveals how the virus doesn't just evade the immune system but actively commandeers the host's cellular machinery in a way never before

For decades, the cellular machinery responsible for building life’s essential proteins was viewed as a simple, unguided assembly line, but new evidence suggests a sophisticated manager has been overseeing the entire operation all along. This molecular coordinator, known as the nascent